Atlas Trials

Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV.

Clinical trial NCT05755659 · UNKNOWN

Trial details

NCT number
NCT05755659
Sponsor
Xijing Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Neoplasms
Start date
2022-07-15
Primary completion
2024-10-20
Enrollment
3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.